Theranostics 2014; 4(6):579-591. doi:10.7150/thno.7688


Polysaccharide Nanosystems for Future Progress in Cardiovascular Pathologies

Amanda Karine Andriola Silva, Didier Letourneur, Cédric Chauvierre

Inserm, U698, Cardiovascular Bio-Engineering; X. Bichat hospital, 46 rue H. Huchard, F-75018, Paris, France; Université Paris 13, Sorbonne Paris Cité, F-93430, Villetaneuse, France.


Natural polysaccharides have received a lot of attention in the biomedical field. Indeed, sources of polysaccharides, extracted or produced from plants, bacteria, fungi or algae, are diverse and renewable. Moreover, recent progresses in polysaccharide chemistry and nanotechnologies allow elaborating new dedicated nanosystems. Polysaccharide-based nanosystems may be designed for interacting in several biological processes. In particular, the atherothrombotic pathology is highly concerned by polysaccharide-mediated recognition. Atherothrombotic diseases, regardless of the anatomical localization, remain the main causes of morbidity and mortality in the industrialized world. This review intends to provide an overview on polysaccharide-based nanosystems as drug delivery systems and targeted contrast agents for molecular imaging with an emphasis on the treatment and imaging of cardiovascular pathologies.

Keywords: Polysaccharides, Nanosystems, Atherothrombosis, Drug delivery, Molecular imaging.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See for full terms and conditions.
How to cite this article:
Silva AKA, Letourneur D, Chauvierre C. Polysaccharide Nanosystems for Future Progress in Cardiovascular Pathologies. Theranostics 2014; 4(6):579-591. doi:10.7150/thno.7688. Available from